Hasil Pencarian - Vjera Nincevic

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes

    Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes oleh Vjera Ninčević, Tea Omanović Kolarić, Hrvoje Roguljić, Tomislav Kizivat, Martina Smolić, Ines Bilić Ćurčić

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Changing the Landscape of Hypertension Management With SGLT2i

    Changing the Landscape of Hypertension Management With SGLT2i oleh Ines Bilić Ćurčić, Vjera Ninčević, Silvija Canecki Varžić, Ivana Prpić Križevac, Jasminka Milas Ahić, Ivica Mihaljević

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy

    Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy oleh Vjera Ninčević, Milorad Zjalić, Tea Omanović Kolarić, Martina Smolić, Tomislav Kizivat, Lucija Kuna, Aleksandar Včev, Ashraf Tabll, Ines Bilić Ćurčić

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Pretreatment of Garlic Oil Extracts Hampers Epithelial Damage in Cell Culture Model of Peptic Ulcer Disease

    Pretreatment of Garlic Oil Extracts Hampers Epithelial Damage in Cell Culture Model of Peptic Ulcer Disease oleh Lucija Kuna, Milorad Zjalic, Tomislav Kizivat, Hrvoje Roguljic, Vjera Nincevic, Tea Omanovic Kolaric, Catherine H. Wu, Aleksandar Vcev, Martina Smolic, Robert Smolic

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

    Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update oleh Hrvoje Roguljic, Hrvoje Roguljic, Hrvoje Roguljic, Vjera Nincevic, Vjera Nincevic, Kristina Bojanic, Kristina Bojanic, Kristina Bojanic, Lucija Kuna, Lucija Kuna, Robert Smolic, Robert Smolic, Aleksandar Vcev, Aleksandar Vcev, Aleksandar Vcev, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Andrijana Vceva, Andrijana Vceva, George Y. Wu, Martina Smolic, Martina Smolic

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: